Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subramaniam Ramanathan

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Pediatric Blood & Cancer|January 16, 2023
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer centerSubramaniam Ramanathan, Maya Prasad, Tushar Vora, et al.
Journal of Adolescent and Young Adult Oncology|July 25, 2020
High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy RegimenKalasekhar Vijayasekharan, Subramaniam Ramanathan, Girish Chinnaswamy, et al.
The Journal of Allergy and Clinical Immunology. Global|October 10, 2022
Haploidentical CD3<sup>+</sup> TCR αβ/CD19<sup>+</sup>-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitisSubramaniam Ramanathan, Liz Veramendi-Espinoza, Benjamin Shillitoe, et al.
Leukemia|April 29, 2026
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemiaAngus Hodder, Avijeet Mishra, Amir Enshaei, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Pediatric Blood & Cancer|January 16, 2023
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer centerSubramaniam Ramanathan, Maya Prasad, Tushar Vora, et al.
Journal of Adolescent and Young Adult Oncology|July 25, 2020
High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy RegimenKalasekhar Vijayasekharan, Subramaniam Ramanathan, Girish Chinnaswamy, et al.
The Journal of Allergy and Clinical Immunology. Global|October 10, 2022
Haploidentical CD3<sup>+</sup> TCR αβ/CD19<sup>+</sup>-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitisSubramaniam Ramanathan, Liz Veramendi-Espinoza, Benjamin Shillitoe, et al.
Leukemia|April 29, 2026
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemiaAngus Hodder, Avijeet Mishra, Amir Enshaei, et al.
Pageof 3